Prognostic value of metastatic pattern in colorectal cancer: a multicenter retrospective analysis in a real-life cohort

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Vatandoust S, Price TJ, Karapetis CS. Colorectal cancer: metastases to a single organ. WJG. 2015;21(41):11767–11776.
   PubMed Web of Science ®Google Scholar
• Yoshino T, Arnold D, Taniguchi H, et al. Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS. Ann Oncol. 2018;29(1):44–70.
   PubMed Web of Science ®Google Scholar
• Prasanna T, Karapetis CS, Roder D, et al. The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern. Acta Oncol (Madr). 2018;57(11):1438–1444.
   PubMed Web of Science ®Google Scholar
• Elias D, Sideris L, Pocard M, et al. Incidence of unsuspected and treatable metastatic disease associated with operable colorectal liver metastases discovered only at laparotomy (and not treated when performing percutaneous radiofrequency ablation). Ann Surg Oncol. 2005;12(4):298–302.
   PubMed Web of Science ®Google Scholar
• Carpizo DR, D’Angelica M. Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease. Ann Surg Oncol. 2009;16(9):2411–2421.
   PubMed Web of Science ®Google Scholar
• Damiens K, Ayoub JPM, Lemieux B, et al. Clinical features and course of brain metastases in colorectal cancer: an experience from a single institution. Curr Oncol. 2012;19:254–258.
   PubMed Web of Science ®Google Scholar
• Koppe MJ, Boerman OC, Oyen WJG, et al. Peritoneal carcinomatosis of colorectal origin: Incidence and current treatment strategies. Ann Surg. 2006;243(2):212–222.
   PubMed Web of Science ®Google Scholar
• Nozue M, Oshiro Y, Kurata M, et al. Treatment and prognosis in colorectal cancer patients with bone metastasis. Oncol Rep. 2002;9:109–112.
   PubMed Web of Science ®Google Scholar
• Riihimaki M, Hemminki A, Sundquist J, et al. Patterns of metastasis in colon and rectal cancer. Sci Rep. 2016;6(1):29765.
   PubMed Web of Science ®Google Scholar
• Holch JW, Demmer M, Lamersdorf C, et al. Pattern and dynamics of distant metastases in metastatic colorectal cancer. Visc Med. 2017;33(1):70–75.
   PubMed Web of Science ®Google Scholar
• Prasanna T, Wong R, Price TJ, et al. Metastasectomy and BRAF mutation: an analysis of survival outcome in metastatic colorectal cancer. J Clin Oncol. 2019;37(15_suppl):3531.
   Web of Science ®Google Scholar
• Rajakannu M, Magdeleinat P, Vibert E, et al. Is cure possible after sequential resection of hepatic and pulmonary metastases from colorectal cancer? Clin Colorectal Cancer. 2018;17(1):41–49.
   PubMed Web of Science ®Google Scholar
• Shah SA, Haddad R, Al-Sukhni W, et al. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J Am Coll Surg. 2006;202(3):468–475.
   PubMed Web of Science ®Google Scholar
• Modest DP, Stintzing S, Von Weikersthal LF, et al. Impact of subsequent therapies on outcome of the FIRE-3/AIO KRK0306 trial: First-line therapy with FOLFIRI plus cetuximab or bevacizumab in patients with KRAS wild-type tumors in metastatic colorectal cancer. J Clin Oncol. 2015;33(32):3718–3726.
   PubMed Web of Science ®Google Scholar
• Goey KKH, Sørbye H, Glimelius B, et al. Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: supported by the ARCAD Group. Eur J Cancer. 2018;100:35–45.
   PubMed Web of Science ®Google Scholar
• Kumar R, Price TJ, Beeke C, et al. Colorectal cancer survival: an analysis of patients with metastatic disease synchronous and metachronous with the primary tumor. Clin Colorectal Cancer. 2014;13(2):87–93.
   PubMed Web of Science ®Google Scholar
• Venook AP, Ou F-S, Lenz H-J, et al. Primary (1°) tumor location as an independent prognostic marker from molecular features for overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC): analysis of CALGB/SWOG 80405 (Alliance). J Cin Oncol. 2017;35(15_suppl):3503.
   Google Scholar
• Tie J, Lipton L, Desai J, et al. KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancer. Clin Cancer Res. 2011;17(5):1122–1130.
   PubMed Web of Science ®Google Scholar
• Yaeger R, Cowell E, Chou JF, et al. RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer. Cancer. 2015;121(8):1195–1203.
   PubMed Web of Science ®Google Scholar